Dr. Khan Siddiqui, Chief Medical Officer at Hyperfine, Inc. “This investment will fill a critical role in providing an affordable, scalable method for directly evaluating the efficacy of interventions to improve infant and child health and neurodevelopment.”
May 18, 2023